MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Alternating hemiplegia of childhood (AHC) as a new presentation of adenylate cyclase 5 (ADCY5)-mutation-associated disease

    C. Max, A. Westenberger, N. Brueggemann, A. Domingo, K. Gruetz, H. Pawlack, A. Weissbach, A.A. Kuehn, J. Spiegler, A.E. Lang, J. Sperner, V.S.C. Fung, J. Schallner, G. Gillessen-Kaesbach, A. Muenchau, C. Klein (Lübeck, Germany)

    Objective: To expand and determine the clinical spectrum associated with mutations in the Adenylate Cyclase 5 gene (ADCY5). Background: Recently, mutations in the ADCY5 gene…
  • 2016 International Congress

    A pilot study of whole exome sequencing in progressive supranuclear palsy

    K.Y. Mok, A. Tucci, R. de Silva, H.R. Morris, A.B. Singleton, H. Houlden, J. Hardy, IPDGC (London, United Kingdom)

    Objective: To identify genetic variants associated with Progressive Supranuclear Palsy (PSP) using whole exome sequencing. Background: PSP is a rare tauopathy but is the second…
  • 2016 International Congress

    The distinguishing clinical features of rapid-onset-parkinson-dystonia (RDP) syndrome due to ATP1A3 mutations

    I.A. Meijer, R.A. Ortega, D. Raymond, N. Lubarr, V. Shanker, W.L. Severt, S. Bressman, L. Ozelius, R. Saunders-Pullman (New York, NY, USA)

    Objective: To determine characteristics that distinguish individuals with presentation suggestive of RDP in ATP1A3 mutation carriers compared with non-carriers. Background: Mutations in the ATP1A3 gene…
  • 2016 International Congress

    A rare genetic transcriptomopathy syndrome involving TAF1 leading to insights into more common neurologic disorders, including X-linked dystonia-parkinsonism (XDP)

    G.J. Lyon (New York, NY, USA)

    Objective: We set out to discover the genetic basis of an X-linked genetic syndrome presenting with global developmental delay, intellectual disability, characteristic facial dysmorphology, generalized…
  • 2016 International Congress

    FBOX07 mutation with juvenile parkinsonism and behavioral disorders

    M. Kuzu, F.N. Durmaz, Ç. Ulukan, H. Kaymakçalan, A.O. Çaglayan, C. Akbostanci (Ankara, Turkey)

    Objective: FBX07 (PARK15) mutations cause juvenile parkinsonism with autosomal ressesive inheritance. Juvenile parkinsonism, pyramidal tract signs and atypical symptoms such as dystonia, chorea, behavioral disturbances,…
  • 2016 International Congress

    Reduced thalamo-cortical functional connectivity in asymptomatic LRRK2 mutation carriers

    D. Vilas, B. Segura, C. Pont-Sunyer, M.J. Martí, Y. Compta, F. Valldeoriola, H. Baggio, M. Quintana, A. Bayés, J. Hernández-Vara, M. Calopa, M. Aguilar, C. Junqué, E. Tolosa (Barcelona, Spain)

    Objective: To characterize MRI functional patterns during resting state in asymptomatic LRRK2 mutation carriers. Background: Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are…
  • 2016 International Congress

    Phenotypic characteristics in GBA-associated Parkinson’s disease (PD): A study in a Greek population

    A.M. Simitsi, C. Koros, N. Papagiannakis, R. Antonelou, M. Moraitou, H. Michelakakis, M. Stamelou, L. Stefanis (Athens, Greece)

    Objective: To evaluate whether there are distinct motor and non-motor symptom characteristics in GBA-associated PD (GBA-PD) in a Greek population. Background: Mutations in the GBA1…
  • 2016 International Congress

    In utero delivery of scAAV9 mediates widespread brain transduction in rats and monkeys: Towards new models of Parkinson’s disease

    M. Bourdenx, L. Chansel-Debordeaux, S. Dovero, V. Grouyhier, N. Dutheil, S. Brun, A. Espagna, L. Groc, Q. Li, C. Jimenez, E. Bezard, B. Dehay (Bordeaux, France)

    Objective: Our objective was to create transgenic mammals using systemic delivery of adeno-associated virus serotype 9 (AAV2/9). Background: The adeno-associated virus serotype 9 (AAV2/9) crosses…
  • 2016 International Congress

    Response to thermal and pain stimulation and genetic variance for pain in patients with Parkinson’s disease – Are they all related?

    A. Khlebtovsky, R. Dabby, Y. Rodity, I. Steiner, R. Djaldetti (Petach Tikva, Israel)

    Objective: To examine whether there is a connection between clinical findings, genetics and QST data of Parkinson's disease(PD) patients and to characterize the genetic mechanisms…
  • 2016 International Congress

    No RAB39B gene mutations in Chinese familial Parkinson’s disease

    J.F. Guo, J.F. Kang, X.X. Yan, B.S. Tang (Changsha, People's Republic of China)

    Objective: To validate the susceptibility to familial PD patients caused by RAB39B in Chinese Han population. Background: Recently, RAB39B mutations c.503C>A and c.574G>A have been…
  • « Previous Page
  • 1
  • …
  • 1585
  • 1586
  • 1587
  • 1588
  • 1589
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley